Compounds > 6-amino-5-(formyl-n-methylamino)-1,3-dimethyluracil
Page last updated: 2024-08-26

6-amino-5-(formyl-n-methylamino)-1,3-dimethyluracil and Leukemia L 1210

6-amino-5-(formyl-n-methylamino)-1,3-dimethyluracil has been researched along with Leukemia L 1210 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnaud, M; Erba, E; Filippeschi, S; Garattini, S; Mantovani, A; Morasca, L; Peri, G; Spreafico, F1

Other Studies

1 other study(ies) available for 6-amino-5-(formyl-n-methylamino)-1,3-dimethyluracil and Leukemia L 1210

ArticleYear
In vitro and in vivo cytotoxicity of 6 amino-5-formyl-methylamino-1,3-dimethyl uracil, a uracilic metabolite of caffeine.
    Toxicology letters, 1982, Volume: 10, Issue:2-3

    Topics: Animals; Caffeine; Cell Division; Female; Humans; In Vitro Techniques; Leukemia L1210; Mice; Mice, Inbred Strains; Uracil

1982